147 related articles for article (PubMed ID: 38149143)
1. Small Cell Oesophageal Carcinoma: A Retrospective Case Series From a UK Tertiary Centre and a Review of the Literature.
Zemerly S; Thurairajasingam K; Deeb B; Tilby M
Cureus; 2023 Nov; 15(11):e49435. PubMed ID: 38149143
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis.
Ding J; Ji J; Zhu W; Zhou K; Han J; Zhang Y; Yu C; Li T; Tao G; Ji F; Zhou X; Pan P
Dis Esophagus; 2013; 26(7):696-702. PubMed ID: 23317069
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of radiotherapy to patients with small cell esophagus carcinoma: an analysis of Surveillance Epidemiology and End Results (SEER) data.
Song Y; Wang W; Tao G; Zhu W; Zhou X; Pan P
Oncotarget; 2016 Mar; 7(13):15474-80. PubMed ID: 26943276
[TBL] [Abstract][Full Text] [Related]
4. Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC?
Nakajima Y; Zenda S; Minashi K; Yano T; Tahara M; Doi T; Onozawa M; Nihei K; Fujii S; Ohtsu A
Int J Clin Oncol; 2012 Dec; 17(6):610-5. PubMed ID: 22041926
[TBL] [Abstract][Full Text] [Related]
5. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
6. Small cell carcinoma of the esophagus.
Jereczek-Fossa B; Airoldi M; Gribaudo S; Ruo Redda MG; Valente G; Orecchia R
Neoplasma; 1999; 46(1):7-11. PubMed ID: 10355527
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG
World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035
[TBL] [Abstract][Full Text] [Related]
8. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.
Wang HH; Zaorsky NG; Meng MB; Wu ZQ; Zeng XL; Jiang B; Jiang C; Zhao LJ; Yuan ZY; Wang P
Onco Targets Ther; 2015; 8():437-44. PubMed ID: 25709477
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
Honma Y; Nagashima K; Hirano H; Shoji H; Iwasa S; Takashima A; Okita N; Kato K; Boku N; Murakami N; Inaba K; Ito Y; Itami J; Kanamori J; Oguma J; Daiko H
Cancer Med; 2020 Jan; 9(2):595-604. PubMed ID: 31794158
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma.
Liu D; Wen J; Chen J; Wang B; Xu X; Zhang Z; Fan M
Front Surg; 2021; 8():655159. PubMed ID: 34395507
[No Abstract] [Full Text] [Related]
11. Chemotherapy with cisplatin or carboplatin in combination with etoposide for small-cell esophageal cancer: a systemic analysis of case series.
Gao R; Zhang Y; Wen XP; Fu J; Zhang GJ
Dis Esophagus; 2014; 27(8):764-9. PubMed ID: 24118373
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 expression and prognosis in definitive radiotherapy patients with neuroendocrine cervical carcinoma.
Li H; Li X; Yang M; Su H; Zhang J; Hu C; Sun Y; Hu D; Chen L
J Clin Transl Res; 2023 Aug; 9(4):272-281. PubMed ID: 37593242
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma.
Meng MB; Zaorsky NG; Jiang C; Tian LJ; Wang HH; Liu CL; Wang J; Tao Z; Sun Y; Wang J; Pang QS; Zhao LJ; Yuan ZY; Ping W
Radiother Oncol; 2013 Mar; 106(3):317-22. PubMed ID: 23498325
[TBL] [Abstract][Full Text] [Related]
15. [A clinicopathological study of small-cell esophageal carcinoma].
Li X; Zhang D; Lai R
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):395-7. PubMed ID: 9387286
[TBL] [Abstract][Full Text] [Related]
16. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
17. Quantitative CT evaluation after two cycles of induction chemotherapy to predict prognosis of patients with locally advanced oesophageal squamous cell carcinoma before undergoing definitive chemoradiotherapy/radiotherapy.
Yan S; Shi YJ; Liu C; Li XT; Zhao B; Wei YY; Shen L; Lu ZH; Sun YS
Eur Radiol; 2023 Jan; 33(1):380-390. PubMed ID: 35927466
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and histochemical analyses of proliferative activity and angiogenesis in small cell carcinoma of the esophagus.
Koide N; Saito H; Suzuki A; Sato T; Koiwai K; Nakamura N; Miyagawa S
J Gastroenterol; 2007 Dec; 42(12):932-8. PubMed ID: 18085349
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic impact of different chemotherapy strategies on small cell esophageal carcinoma].
Shen W; Deng W; Li N; Wei C; Luo S
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):780-3. PubMed ID: 26813600
[TBL] [Abstract][Full Text] [Related]
20. Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional Disease.
Jeene PM; Geijsen ED; Muijs CT; Rozema T; Aleman BMP; Muller K; Baas JM; Nuyttens JJ; Wouterse S; Braam PM; Oppedijk V; Ceha HM; Cnossen J; Spruit P; Bongers EM; Berbée M; Mook S; Hulshof MCCM
Am J Clin Oncol; 2019 Jun; 42(6):534-538. PubMed ID: 31021827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
